| Business Summary | | Abiomed,
Inc.
is
a
developer,
manufacturer,
and
marketer
of
medical
products
designed
to
safely
and
effectively
assist
or
replace
the
pumping
function
of
the
failing
heart.
The
Company's
current
commercial
products
and
primary
products
under
development
are
the
BVS
product
line
and
the
AbioCor
system,
respectively.
Both
of
these
products
are
systems,
or
product
lines,
that
consist
of
various
component
products.
In
addition,
the
Company
is
in
the
early
stages
of
research
and
development
of
other
potential
products
for
heart
failure
patients. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Abiomed
Inc.
is
engaged
in
the
research,
development
and
sale
of
medical
devices
with
a
primary
focus
on
cardiac
assist
and
heart
replacement
systems.
For
the
three
months
ended
6/30/01,
revenues
rose
2%
to
$6
million.
Net
loss
totaled
$6.3
million,
up
from
$2
million.
Revenues
reflect
increased
international
sales
of
BVS(R)
blood
pumps.
Higher
loss
reflects
higher
research
and
development
costs
for
the
AbioCor
and
Penn
State
Heart
implantable
replacement
hearts. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| David Lederman, Ph.D., 55 Chairman,
Pres, CEO | $516K | John Thero, 39 Sr.
VP-Fin., Treasurer, CFO | 259K | James Koert Sr. VP, Market Devel. | -- | Robert T. Kung, Ph.D., 56 Sr.
VP and CSO | 266K | Eugene Rabe, 44 Sr.
VP- Global Sales and Services | 249K | Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|